科新发展发布与实控人连宗盛签署定增认购协议，涉重大关联交易

事件概述

山西科新发展股份有限公司（证券代码：600234，简称“科新发展”）于2026年3月13日公告，与公司实际控制人连宗盛先生签署了《附条件生效的股份认购协议》，拟向其定向发行A股募集资金总额约3.01亿元人民币。此次发行构成关联交易，但不属于重大资产重组。

关键要点及交易细节

• 认购对象与金额：连宗盛先生拟以现金方式认购公司新增发行的26,252,097股A股，拟募集资金总额为301,374,100元人民币。认购金额和最终发行规模将以监管部门审批结果为准。
• 认购价格：本次定增价格为11.48元/股，不低于定价基准日前20个交易日公司A股均价的80%。若公司在定价基准日至发行日期间发生派息、送股、资本公积转增股本等事项，发行价格将作相应调整。
• 发行审批流程：该项目已获董事会审议通过，尚需股东大会审议通过、上交所审核通过及中国证监会同意注册后方可实施，存在一定不确定性。
• 限售期安排：连宗盛认购的股份自登记之日起锁定36个月，限售期内不得转让。期间如有分红转增等衍生股份，同样受限售约束。
• 资金用途：本次募集资金将全部用于补充公司流动资金，旨在提升公司资金实力、改善流动性、优化资产负债结构、提升抗风险能力。
• 过往关联交易：过去12个月，公司及子公司未与连宗盛发生领取薪酬之外的其他关联交易，也未与其他关联人发生同类别交易。

实控人连宗盛背景详解

连宗盛通过深圳市科新实业控股有限公司及其一致行动人深圳市派德壹盛投资合伙企业（有限合伙）合计控制公司28.23%股份，为公司实际控制人。连宗盛在多家企业担任董事、高管或持大比例股权，具备丰富的投资及实业管理经验。

认购协议主要内容

• 协议于2026年3月13日签署，双方约定连宗盛以自有或自筹合法资金全额现金认购，上市公司不得直接或间接提供财务资助、补偿或其他协议安排。
• 认购股份登记及交付流程严格遵循中国证监会、上交所及中证登上海分公司相关规定。
• 违约责任明确，如一方违约需全额赔偿对方实际经济损失。若因监管要求或资本市场变化，经双方协商可解除协议且不构成违约。
• 争议解决采用深圳国际仲裁院仲裁。
• 协议生效需满足董事会、股东会、上交所及证监会等全部审批通过。

对公司及股东的影响（投资者需重点关注）

• 资金补充：定增有助于公司补充流动资金，提升总资产和净资产规模，改善资产负债结构，增强抗风险能力。
• 控制权变化：本次定增不会导致公司控制权发生变化，也不会产生实控人及关联人占用公司资金、资产或担保的情形。
• 实控人增持：实控人以真金白银认购，体现对公司未来发展的信心，或可提振市场信心。
• 股份稀释：定增将稀释原有股东持股比例，但有助于公司长远发展。
• 审批不确定性：该事项尚需多重监管审批，最终能否实施存在不确定性，投资者需注意相关风险。
• 限售安排：本次认购股份锁定36个月，有助于维护市场稳定，体现长期投资态度。

关键会议及决策流程

• 董事会、独立董事、审计委员会、战略发展委员会均已审议通过相关议案，关联董事回避表决。
• 股东大会将进一步审议，关联方放弃对本议案投票权。
• 最终实施需获上交所审核通过及证监会注册批准。

结论（对股价的潜在影响）

本次公告涉及公司实控人现金认购大额定增相关事项，属于重大关联交易，且募集资金将直接补充流动资金，改善财务结构，显示实控人对公司发展高度认可和支持。若定增顺利推进，预计对公司长期价值有积极作用，或对公司股价构成正面影响。但由于事项尚需股东大会、上交所、证监会多重审批，存在一定不确定性，投资者应关注后续进展。

免责声明：本新闻稿仅供投资者参考，不构成任何投资建议。股市有风险，投资需谨慎。请投资者关注公司后续公告及相关监管部门审批进展，理性判断投资风险。

English Version

Kexin Development Signs Conditional Share Subscription Agreement with Actual Controller Lian Zongsheng: Details of Major Related Party Transaction

Event Overview

On March 13, 2026, Shanxi Kexin Development Co., Ltd. (Stock code: 600234; “Kexin Development”) announced the signing of a “Conditional Share Subscription Agreement” with its actual controller, Mr. Lian Zongsheng. The company plans to issue 26,252,097 new A-shares to Lian for a total consideration of RMB 301,374,100 in cash. This constitutes a related party transaction but does not amount to a major asset restructuring.

Key Points and Transaction Details

• Subscriber and Amount: Mr. Lian Zongsheng will subscribe for 26,252,097 new A-shares with cash, for a total subscription amount of RMB 301.3741 million. The final amount and size are subject to regulatory approval.
• Issue Price: The subscription price is RMB 11.48 per share, not less than 80% of the average trading price of the company’s A-shares in the 20 trading days before the pricing benchmark date. If the company implements dividends, bonus shares, or capital reserve transfers before the issue date, the price will be adjusted accordingly.
• Approval Process: The proposal has been approved by the Board but still requires approval from the shareholders’ meeting, Shanghai Stock Exchange (SSE) review, and China Securities Regulatory Commission (CSRC) registration. There is some uncertainty in implementation.
• Lock-up Period: The newly issued shares subscribed by Lian Zongsheng will be locked for 36 months from the date of registration; any derived shares from dividends or capital increases are also subject to the lock-up.
• Use of Proceeds: All proceeds will be used to supplement the company’s working capital, improve liquidity, optimize the capital structure, and enhance risk resistance.
• Past Related Transactions: In the past 12 months, except for remuneration, there have been no other related transactions of this kind between the company and Mr. Lian or other related parties.

Background of Actual Controller Lian Zongsheng

Lian Zongsheng controls a total of 28.23% of the company’s shares through Shenzhen Kexin Industrial Holding Co., Ltd. and its concerted party, Shenzhen Paide Yisheng Investment Partnership (LLP). Lian holds management or substantial shareholdings in several enterprises and has extensive investment and operational experience.

Key Terms of the Subscription Agreement

• Signed on March 13, 2026, Lian will use his own or self-raised legal funds to subscribe in cash. The company will not provide direct or indirect financial assistance or compensation.
• The subscription and registration process strictly follows CSRC, SSE, and CSDC Shanghai Branch rules.
• In case of default, the breaching party must fully compensate the counterparty for all actual economic losses. The agreement can be terminated by mutual consent if regulatory or market conditions change significantly, without constituting a breach.
• Disputes will be arbitrated at the Shenzhen International Arbitration Court.
• The agreement takes effect only after all necessary approvals from the Board, shareholders, SSE, and CSRC.

Impact on Company and Shareholders (Investor Focus)

• Capital Infusion: The placement will strengthen working capital, boost total and net assets, improve capital structure, and reduce leverage and risk.
• No Change in Control: The placement will not change company control, nor result in related parties occupying company assets or funds, or guarantees.
• Controller’s Commitment: The controlling shareholder’s cash subscription signals strong confidence in the company’s future and may boost market sentiment.
• Share Dilution: The placement will dilute existing shareholders, but aims to support long-term growth.
• Uncertainty Risk: Implementation is subject to multiple layers of regulatory approval; investors should note the related risks.
• Lock-up Arrangement: The 36-month lock-up reflects a long-term investment attitude and benefits market stability.

Key Meetings and Decision Process

• The Board, independent directors, Audit Committee, and Strategic Development Committee have all approved the proposal, with related directors abstaining from voting.
• The shareholders’ meeting will review the proposal, with related parties abstaining from voting.
• Final implementation requires SSE and CSRC approval and registration.

Conclusion (Potential Share Price Impact)

This announcement involves a major related party transaction where the actual controller will subscribe and inject significant capital into the company. The cash infusion will directly enhance liquidity, improve financial structure, and demonstrates the controller’s strong support for the company’s strategy and prospects. If the placement proceeds as planned, it is likely to have a positive long-term impact on company value and could support the share price. However, as the transaction is subject to multiple regulatory approvals, there remains some uncertainty; investors should watch for official updates.

Disclaimer: This news article is for informational purposes only and does not constitute investment advice. Stock market investments involve risk; investors should pay attention to subsequent official disclosures and regulatory updates, and make prudent investment decisions.

View 科新发展 Historical chart here